Navigation Links
Ohio Capital Fund Announces Sponsorship of Minority Business Conference

COLUMBUS, Ohio, Nov. 30 /PRNewswire/ -- The Ohio Capital Fund today underscored its support for one of the nation's first minority business early-stage capital summits. The event, to be held in Cleveland December 3, is called "Transforming the Landscape of Business in America: A Minority Business Early-Stage Capital Summit." It will feature several speakers including investors, national minority business leaders and local minority entrepreneurs.

"The Ohio Capital Fund's mission is to attract Venture Capital investment to Ohio to support our state's early-stage businesses and minority business success is a big part of our expectations," said Paul Cohn , Regional Director of Fort Washington Capital Partners Group, the manager of the Ohio Capital Fund. "We are proud to join the other event sponsors to make this important Jumpstart Initiative possible and we encourage minority entrepreneurs to take advantage of this opportunity."

Ohio has recently experienced impressive results when it comes to attracting early and seed-stage business investment. A recent study conducted by the Ohio State University's Fisher College of Business found that early-stage investment in Ohio increased by 50% in 2008 over the previous year. Further impressing experts was the fact that this unprecedented expansion occurred while national averages for this stage of investment decreased by 20%.

"Sectors of Ohio's economy that have proven most successful in attracting early-stage investment are specialty materials, information technology and energy with the largest gains in health care and biomedical sciences," said Cohn. "This summit will spotlight some of the minority leaders in these sectors and educate others who want to follow along their path of success. They will also offer suggestions to avoid many of the pitfalls that start-up businesses experience."

Other Sponsors of the Minority Business Early-Stage Capital Summit include the Cleveland Clinic, Initiative for a Competitive Inner City, Institute for Entrepreneurial Thinking, Marathon Club, Ohio Department of Development, TechColumbus, and Thompson Hine. For more information about the summit or to register for the event. click

About Ohio Capital Fund

Established by the State of Ohio through legislative mandate to help increase private investment in Ohio companies in the seed or early stage of business development, The Ohio Capital Fund receives oversight from the Ohio Venture Capital Authority (OVCA). The OVCA is comprised of nine members, including the Ohio Tax Commissioner and the Director of the Ohio Department of Development as well as seven members appointed by the Governor from the general public. For more information visit:

SOURCE Ohio Capital Fund

SOURCE Ohio Capital Fund
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals
2. Amgen to Present at Lazard Capital Healthcare Conference
3. Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference
4. Regado Biosciences to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17, 2009
5. NeoGenomics To Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 18, 2009
6. Genoptix Announces Participation at Lazard Capital Management 6th Annual Healthcare Conference
7. Neurobiological Technologies Announces Intent to File Form 25 to Delist Common Stock From the NASDAQ Capital Market
8. Kansas Bioscience Authority Commits $50 Million to Increase Venture Capital, Accelerate Bioscience Business Growth
9. Matan Companies Teams with Federal Capital Partners to Finance the National Cancer Institute at Riverside Research Park in Frederick, Maryland
10. Emissary Capital Group Initiates Coverage on Sinobiopharma
11. American Capital Receives $182 Million In Proceeds From Sale of Axygen Bioscience
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... CA (PRWEB) , ... June 23, 2016 , ... ... software, is exhibiting at the Pennsylvania Convention Center and will showcase its product’s ... conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials ...
(Date:6/23/2016)... June 23, 2016 ... report to its pharmaceuticals section with historic and ... and much more. Complete report on ... pages, profiling 15 companies and supported with 261 ... . The Global Cell ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016 On Monday, the ... to industry to share solutions for the Biometric Exit ... Customs and Border Protection (CBP), explains that CBP intends ... departing the United States , in ... to defeat imposters. Logo - ...
(Date:6/9/2016)... 9, 2016  Perkotek an innovation leader in attendance control systems is proud to ... hours, for employers to make sure the right employees are actually signing in, and ... ... ... ...
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
Breaking Biology News(10 mins):